176 related articles for article (PubMed ID: 9614926)
1. Immune response to an epitope of the NS4 protein of hepatitis C virus in HCV-related disorders.
Longombardo G; Ferri C; Marchi S; Costa F; Lombardini F; Vacri L; Bombardieri S; Migliorini P
Clin Immunol Immunopathol; 1998 May; 87(2):124-9. PubMed ID: 9614926
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
[TBL] [Abstract][Full Text] [Related]
3. Identification of immunodominant epitopes in the core and non-structural region of hepatitis C virus by enzyme immunoassay using synthetic peptides.
Park HJ; Byun SM; Ha YJ; Ahn JS; Moon HM
J Immunoassay; 1995 May; 16(2):167-81. PubMed ID: 7543117
[TBL] [Abstract][Full Text] [Related]
4. Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein.
Sällberg M; Rudén U; Wahren B; Magnius LO
Clin Exp Immunol; 1993 Mar; 91(3):489-94. PubMed ID: 7680297
[TBL] [Abstract][Full Text] [Related]
5. Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia.
Gabrielli A; Zhang ZX; Cherubini G; Candela M; Savoldi S; Manzin A; Clementi M; Amoroso A; Sallberg M
Clin Exp Immunol; 1996 Jul; 105(1):59-64. PubMed ID: 8697636
[TBL] [Abstract][Full Text] [Related]
6. Comparison of genotyping and serotyping methods for the identification of hepatitis C virus types.
Tisminetzky S; Gerotto M; Pontisso P; Chemello L; Prescott LE; Rose KA; Baralle F; Simmonds P; Alberti A
J Virol Methods; 1995 Nov; 55(3):303-7. PubMed ID: 8609196
[TBL] [Abstract][Full Text] [Related]
7. [Use of synthetic peptides as additional antigens for detecting antibodies to hepatitis C virus].
Semiletov IuA; Firsova TV; Kruglov IV; Alekseenkova TI; Petrakova NV; Kalinina TI; Shibnev VA
Vopr Virusol; 1998; 43(3):107-9. PubMed ID: 9702806
[TBL] [Abstract][Full Text] [Related]
8. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
9. Reduced antibody reactivity to hepatitis C virus antigens in hemodialysis patients coinfected with hepatitis B virus.
Devesa M; Khudyakov YE; Capriles F; Blitz L; Fields HA; Liprandi F; Pujol FH
Clin Diagn Lab Immunol; 1997 Nov; 4(6):639-42. PubMed ID: 9384281
[TBL] [Abstract][Full Text] [Related]
10. Artificial NS4 mosaic antigen of hepatitis C virus.
Chang JC; Ruedinger B; Cong M; Lambert S; Lopareva E; Purdy M; Holloway BP; Jue DL; Ofenloch B; Fields HA; Khudyakov YE
J Med Virol; 1999 Dec; 59(4):437-50. PubMed ID: 10534724
[TBL] [Abstract][Full Text] [Related]
11. Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassay.
Gish RG; Warmerdam MT; Zeldis JB; Keeffe EB; Nakazato P; Lim J; Cox K; Kuramoto IK; Fry KE; Yarbough PO
Viral Immunol; 1993; 6(1):49-54. PubMed ID: 7682814
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of core and NS4B synthetic peptide-based immunoassays for the detection of hepatitis C virus antibodies in clinical samples from Cameroon, Central Africa.
Njouom R; Nerrienet E; Budkowska A; Maillard P; Rousset D; Kalinina O; Mavromara P;
J Clin Virol; 2010 Sep; 49(1):61-4. PubMed ID: 20621554
[TBL] [Abstract][Full Text] [Related]
13. [Immunoreactivity studies on synthetic peptides deriving from immunodominant region of hepatitis C virus NS5a gene].
Shi LL; Dou XG; Feng GH; Fields H; Khudyakov Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):344-7. PubMed ID: 15650785
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping of the NS4 and NS5 gene products of hepatitis C virus and the use of a chimeric NS4-NS5 synthetic peptide for serodiagnosis.
Rosa C; Osborne S; Garetto F; Griva S; Rivella A; Calabresi G; Guaschino R; Bonelli F
J Virol Methods; 1995 Oct; 55(2):219-32. PubMed ID: 8537460
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a linear epitope in the nonstructural region 4 of hepatitis C virus with reactivity to seroconversion antibodies.
Wienhues U; Ihlenfeldt HG; Seidel C; Schmitt U; Kraas W; Jung G
Virology; 1998 Jun; 245(2):281-8. PubMed ID: 9636367
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a multiple peptide assay for typing of antibodies to the hepatitis C virus: relation to genomic typing by the polymerase chain reaction.
Zhang ZX; Yun ZB; Chen M; Sönnerborg A; Sällberg M
J Med Virol; 1995 Jan; 45(1):50-5. PubMed ID: 7536231
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA.
Rodr Guez-L Pez M; Riezu-Boj JI; Ruiz M; Berasain C; Civeira MP; Prieto J; Borr S-Cuesta F
J Gen Virol; 1999 Mar; 80 ( Pt 3)():727-738. PubMed ID: 10092013
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
19. Identification of antigenic sites on three hepatitis C virus proteins using phage-displayed peptide libraries.
Pereboeva LA; Pereboev AV; Morris GE
J Med Virol; 1998 Oct; 56(2):105-11. PubMed ID: 9746064
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.
Kerkar N; Choudhuri K; Ma Y; Mahmoud A; Bogdanos DP; Muratori L; Bianchi F; Williams R; Mieli-Vergani G; Vergani D
J Immunol; 2003 Feb; 170(3):1481-9. PubMed ID: 12538711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]